Fisher & Paykel Healthcare
(ASX:FPH) has released its new OSA Full Face Mask in the USA.
Following confirmation to sell the product across the country, the corporation has also upgraded its revenue and earnings guidance for the financial year.
The new mask for obstructive sleep apnoea (OSA), is already available in Australia, Canada, New Zealand and Europe and will be available in other regions upon receiving the relevant regulatory clearances.
According to the the sleep apnoea organisation, it's estimated that 22 million Americans alone suffer from the disorder.
Shares in Fisher & Paykel Healthcare
(ASX:FPH) closed flat at $15.96 on Friday.
